Action of the Terminal Complement Pathway on Cell Membranes

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• The complement pathway is a crucial part of innate immunity, targeting pathogens.
• Late complement activation involves C5a receptors (C5aR1, C5aR2) and the Membrane Attack Complex (MAC).
• Host cells possess inhibitors like clusterin and CD59 to prevent complement-mediated damage.

Purpose of the Study:

• To review recent molecular and structural insights into C5a receptor activation and MAC assembly regulation.
• To explore the molecular basis of inflammatory diseases resulting from dysregulated terminal complement effectors.
• To outline potential crosstalk between C5a receptor signaling and MAC-mediated responses.

Main Methods:

• Literature review of molecular and structural studies.
• Analysis of disease mechanisms linked to complement dysregulation.
• Synthesis of information on C5a receptor and MAC pathways.

Main Results:

• Recent advances in understanding C5a receptor (C5aR1, C5aR2) activation and modulation.
• Insights into the regulation of Membrane Attack Complex (MAC) assembly.
• Identification of shared inflammatory disease outcomes due to dysregulated terminal complement effectors.

Conclusions:

• Dysregulation of terminal complement effectors, including C5a receptors and MAC, underlies inflammatory diseases.
• Crosstalk and synergy between C5a receptor activation and MAC-mediated cellular responses contribute to disease pathogenesis.
• Further research into these interactions may reveal novel therapeutic targets.